
### [NCIT:C5585](http://purl.obolibrary.org/obo/NCIT_C5585)
**Label:** Skin Sarcoma

**Subclasses:** [NCIT:C5615](http://purl.obolibrary.org/obo/NCIT_C5615) (Cutaneous Liposarcoma), [NCIT:C5576](http://purl.obolibrary.org/obo/NCIT_C5576) (Cutaneous Undifferentiated Pleomorphic Sarcoma), [NCIT:C27719](http://purl.obolibrary.org/obo/NCIT_C27719) (Cutaneous Radiation-Related Angiosarcoma), [NCIT:C4489](http://purl.obolibrary.org/obo/NCIT_C4489) (Skin Angiosarcoma), [NCIT:C4484](http://purl.obolibrary.org/obo/NCIT_C4484) (Cutaneous Leiomyosarcoma), [NCIT:C9112](http://purl.obolibrary.org/obo/NCIT_C9112) (Classic Kaposi Sarcoma), [NCIT:C4490](http://purl.obolibrary.org/obo/NCIT_C4490) (Skin Lymphangiosarcoma), [NCIT:C3550](http://purl.obolibrary.org/obo/NCIT_C3550) (Skin Kaposi Sarcoma), [NCIT:C40379](http://purl.obolibrary.org/obo/NCIT_C40379) (Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema), 

**Class expressions from DL-Learner:**

- [UBERON:0002097](http://purl.obolibrary.org/obo/UBERON_0002097) (skin of body) 53.85%
- [UBERON:0002067](http://purl.obolibrary.org/obo/UBERON_0002067) (dermis) 53.85%
- Thing 52.89%
- [NCIT:C12964](http://purl.obolibrary.org/obo/NCIT_C12964) (Connective and Soft Tissue) 39.32%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38348](http://purl.obolibrary.org/obo/NCIT_C38348) (MSN-ALK Fusion Protein Expression))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38347](http://purl.obolibrary.org/obo/NCIT_C38347) (P13K-AKT Pathway Deregulation))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38346](http://purl.obolibrary.org/obo/NCIT_C38346) (MYC Pathway Deregulation))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38345](http://purl.obolibrary.org/obo/NCIT_C38345) (JUN Pathway Deregulation))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38344](http://purl.obolibrary.org/obo/NCIT_C38344) (RAS-RAF Pathway Deregulation))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38343](http://purl.obolibrary.org/obo/NCIT_C38343) (JAK-STAT Pathway Deregulation))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38341](http://purl.obolibrary.org/obo/NCIT_C38341) (Postgerminal Center B-Lymphocyte of Unknown Differentiation Stage))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3834](http://purl.obolibrary.org/obo/NCIT_C3834) (Ataxic Gait))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38339](http://purl.obolibrary.org/obo/NCIT_C38339) (Postgerminal Center Memory B-Lymphocyte))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38334](http://purl.obolibrary.org/obo/NCIT_C38334) (Postgerminal Center Marginal Zone B-Lymphocyte))) 39.20%


